Share chart Dr. Reddy's Laboratories
Extended chart
Simple chart
About Dr. Reddy's Laboratories
Dr. Reddy’s (Dr. Reddy’s Laboratories) — международная индийская фармацевтическая компания со штаб-квартирой в Хайдарабаде, вторая по объёмам продаж лекарственных средств в Индии (2015, после Sun Farmaceuticals). Выпускает как дженерики (Цетрин, Экзифин), так и патентованные препараты (Ибуклин, Декспан Плюс, Кеторол-гель), также оказывает фармацевтические услуги, производит фармсубстанции. Основана в 1984 году доктором Анджи Редди (англ. Anji Reddy). Кроме национального, работает на международных рынках, в основном — в развивающихся странах. more details| IPO date | 2001-04-11 |
|---|---|
| ISIN | US2561352038 |
| Industry | Pharmaceuticals |
| Sector | Health Care |
| Валюта | usd |
| Валюта отчета | inr |
| Див.доход ао | 0.5804 |
| Дивиденд ао | 0.575 |
| Сайт | https://www.drreddys.com |
| Цена ао | 13.93 |
| Change price per day: | 0% (13.93) |
|---|---|
| Change price per week: | +3.11% (13.51) |
| Change price per month: | +5.37% (13.22) |
| Change price per 3 month: | +0.8689% (13.81) |
| Change price per half year: | -4.33% (14.56) |
| Change price per year: | 0% (13.93) |
| Change price per 3 year: | -74.79% (55.26) |
| Change price per 5 year: | -80.11% (70.04) |
| Change price per 10 year: | -78.5% (64.8) |
| Change price per year to date: | -11.1% (15.67) |
|
|
Underestimation
|
Efficiency
|
|||||||||||||||||||||||||||||||||||||
Dividends
|
Debt
|
Growth impulse
|
|||||||||||||||||||||||||||||||||||||
| Institutions | Volume | Share, % |
|---|---|---|
| Blackrock Inc. | 3001420 | 1.8 |
| Royal Bank of Canada | 2219807 | 1.33 |
| Renaissance Technologies, LLC | 1860795 | 1.12 |
| Goldman Sachs Group Inc | 1837163 | 1.1 |
| Robeco Institutional Asset Management B.V. | 1725380 | 1.03 |
| Aikya Investment Management Ltd | 1096573 | 0.66 |
| Vanguard Group Inc | 1038258 | 0.62 |
| Dimensional Fund Advisors LP | 829310 | 0.5 |
| Morgan Stanley | 818552 | 0.49 |
| Man Group PLC | 765193 | 0.46 |
| ETF | Share, % | Profitability for 1 year, % | Dividends, % |
|---|---|---|---|
| First Trust Chindia ETF | 3.46 | 12.74 | 0.21 |
| First Trust BICK Index Fund | 2.62 | 21.62 | 1.46 |
| 3.04 | 17.18 | 0.83 |
| Head | Job title | Payment | Year of birth |
|---|---|---|---|
| Mr. Gunupati Venkateswara Prasad B.E. | Co-Chairman, MD & Member of Management Council | 2.25M | 1960 (65 years) |
| Mr. Erez Israeli M.B.A. | CEO & Member of the Management Council | N/A | 1968 (57 years) |
| Mr. Deepak Sapra M.B.A. | CEO of API & Services & Member of Management Council | N/A | 1975 (50 years) |
| Ms. Archana Bhaskar B.Sc., M.B.A. | EVP, Head of Corporate Communications, Chief Human Resources Officer & Member of Management Council | N/A | 1967 (58 years) |
| Mr. Sanjay Sharma B.Tech. | Executive VP, Global Head of Global Manufacturing & Member of Management Council | N/A | 1968 (57 years) |
| Mr. Patrick Aghanian B.A., M.B.A. | CEO of European Generics & Member of Management Council | N/A | 1965 (60 years) |
| Mr. Kallam Satish Reddy B.Tech., M.S. | Chairman of the Board & Member of the Management Council | 1.38M | 1967 (58 years) |
| Mr. Venkata Ramana Motupalli M.B.A. | CEO of Branded Markets - India & Emerging Countries and Member of Management Council | N/A | 1969 (56 years) |
| Mr. Mannam Venkatanarasimham | CFO & Member of the Management Council | ||
| Mr. Krishna K. Venkatesh B.Pharma M.S. | Global Head of Quality and Pharmacovigilance & Member of the Management Council | 1973 (52 years) |
Address: India, Hyderabad, 8-2-337 Road No. 3 - open in Google maps, open in Yandex maps
Website: https://www.drreddys.com
Website: https://www.drreddys.com
